Jul 2, 2026
Jul 2, 2026
Jul 2, 2026
Jul 2, 2026
Jul 2, 2026
Jul 2, 2026
Jul 2, 2026
Jul 2, 2026
Insilico Medicine just inked a massive $2.5 billion deal with SK Biopharmaceuticals, pushing AI into the spotlight for neuroimmune drug discovery. What's next for the biotech world?